Misoprostol in labour induction of term pregnancy: a meta-analysis
Xiao-mao LI; Jing WAN; Cheng-fang XU; Yu ZHANG; Li FANG; Zhong-jie SHI; Kai LI.
Chinese Medical Journal
; (24): 449-452, 2004.
Artículo en Inglés | WPRIM | ID: wpr-346653
Documentos relacionados
A Comparison of the Efficacy and Safety of Mifepristone and Misoprostol Versus Misoprostol alone for Induction of Labour in Nigerian Women with Intrauterine Fetal Death: A Triple Blind Randomized Controlled Trial.
Continued versus discontinued oxytocin stimulation in the active phase of labour (CONDISOX): individual management based on artificial intelligence - a secondary analysis.
Third stage of labor: evidence-based practice for prevention of adverse maternal and neonatal outcomes.
Impact of discontinuing oxytocin in active labour on neonatal morbidity: an open-label, multicentre, randomised trial.
Time from insertion to expulsion of cervical ripening balloon in preterm versus term inductions of labor.
Trends and regional variations in prescriptions dispensed to stimulate uterine contractions at the end of pregnancy in Belgium: A community-based study from 2003 to 2018.
Pharmacokinetics and safety of inhaled oxytocin compared with intramuscular oxytocin in women in the third stage of labour: A randomized open-label study.
The physiology and pharmacology of oxytocin in labor and in the peripartum period.
Continued versus discontinued oxytocin stimulation in the active phase of induced labour: Factors associated with unexpectedly high rates of conversion to open label oxytocin in the CONDISOX trial.
[Did the use of Cytotec in obstetrics per se constitute a treatment error?]